National clinical director for antimicrobial resistance and infection prevention and control He is working across the country to develop interoperable digital systems and databases that will enable machine learning and AI systems at scale alongside existing clinical pathways. He is developing a unified national strategy around infections management to encompass clinical care, prevention, diagnostics, training, treatment, antimicrobial resistance and measurement. He is also improving the measurement and definitions of sepsis and infection to assist epidemiology, research and policy and developed the suspicion of sepsis infection coding set that is used to determine the infection and sepsis burden across England. To this end, he has worked to standardise the country to using NEWS2 as a single language of sickness and communication between healthcare professionals across the whole patient pathway. He has worked to improve processes in the recognition, escalation, communication and response to the deteriorating patient. This is now endorsed by the World Health Organization and has been disseminated internationally. To this end he has developed and lead on the oximetry at home and virtual ward models, and the COVID management guidance/policy in all settings and evidence for the role of oximetry for all patient groups. Professor Matt Inada-Kim is consultant in Acute Medicine at Hampshire Hospitals, National Clinical Director for Infection management, Antimicrobial Resistance and Deterioration, National Clinical Lead for COVID wards, Chair of the COVID pathways group at NHS England and Clinical Director for digital innovation at Wessex AHSN. She also has a long track record of teaching and training health professionals and is Chair of the Addictions Faculty of the Royal College of Psychiatrists. Her primary research aim is to conduct clinically relevant research into the harms of alcohol use, specifically the impact on clinical outcomes in terms of prevention, engagement and response to treatment.
Her clinical roles include developing an integrated alcohol strategy across local services, offering direct clinical care, and work with Regulatory Bodies including the GMC. Her priority is to improve outcomes for patients with alcohol use disorders (AUD) and co-morbid physical and mental health conditions by research, teaching, policy, and clinical practice. Professor Julia Sinclair is Professor of addiction psychiatry and leads the alcohol care team at University Hospital Southampton. National specialty adviser for alcohol dependence Older people and integrated person-centred care.Antimicrobial resistance and infection prevention and control.Current national clinical directors and specialty advisers The National Clinical Directors and National Specialty Advisers are practicing clinicians from across England who work part-time at NHS England, providing clinical leadership, advice, input and support across distinct areas of NHS conditions and services ranging from cancer and cardiovascular disease to urgent and emergency care and major trauma in line with the NHS Long Term Plan. National clinical directors and specialty advisers
0 kommentar(er)
